# of Displayed Technologies: 3 / 3

Applied Category Filter (Click To Remove): Vaccines


A Novel Vectored Vaccine Against Human Norovirus
TS-037664 — A live recombinant vesicular stomatitis virus (VSV)-vector vaccine composition for human norovirus.
Human norovirus (HuNoV) is a major causative agent of foodborne gastroenteritis worldwide. It is estimated that over 90% of outbreaks of acute nonbacterial gastroenteritis are caused by noroviruses. Healthcare facilities, including nursing homes and hospitals, are the most commonly reported place …
  • College: College of Food, Agricultural, and Environmental Sciences (CFAES)
  • Inventors: Li, Jianrong; Ma, Yuanmei
  • Licensing Officer: Dahlman, Jason "Jay"

Selective Delipidation of Mycobacterium bovis BCG enhances its Vaccine Potential against TB
TS-037463 — A novel method to increase vaccine effectiveness for TB
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), is an infectious disease that kills one person every 21 seconds. TB is the current leading cause of death worldwide due to a single infectious organism, overtaking AIDS and malaria. TB treatment requires several months to years of che…
  • College: College of Medicine (COM)
  • Inventors: Torrelles, Jordi; Moliva, Juan
  • Licensing Officer: Norris, Francis "Frank"

Silvestrol as an Immune Adjuvant for Vaccines
TS-014782 — Silvestrol promotes the prevention and treatment of various cancers as an immune adjuvant.
Molecular changes due to malignant tumors and toxicity of chemotherapeutic regimen suppress the immune system of cancer patients. This immunosuppression also leaves patients vulnerable to opportunistic infections and reactivation of latent viral or mycobacterial infections. Immunostimulation, or a…
  • College: College of Medicine (COM)
  • Inventors: Baiocchi, Robert; Grever, Michael; Kinghorn, Alan "Dr. A. Douglas Kinghorn"; Lucas, David; Patton, John
  • Licensing Officer: Paschall, Christopher

Loading icon